This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wyeth. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Jonathon P. Golas: Innovator in Tumor-initiating Cells
Introduction
Jonathon P. Golas is an accomplished inventor based in Hewitt, New Jersey. He has made significant contributions to the field of cancer research, particularly in understanding tumor-initiating cells.
Latest Patents
Golas holds a patent for "Tumor-initiating cells and methods for using same." This patent includes isolated and enriched tumor-initiating cell populations, methods for preparing these cells, and their potential uses in cancer therapies.
Career Highlights
Currently, Jonathon Golas works at Wyeth, a leading biopharmaceutical company known for its innovative approaches in medicine and treatment solutions. His work focuses on groundbreaking research that has the potential to change the landscape of cancer treatment.
Collaborations
Throughout his career, Golas has collaborated with notable colleagues such as Marc Isaac Damelin and Kenneth G. Geles. Together, they have shared insights and expertise, contributing to the advancement of knowledge in their field.
Conclusion
Jonathon P. Golas stands out as a dedicated inventor whose work on tumor-initiating cells has opened new avenues for cancer research. His patented innovations continue to inspire colleagues and advance understanding in oncological therapies.